Michael Donald Orlando

Practice Details

• Languages
  French
• Firm Information
  Position

  Partner

  Firm Name

  Sheppard Mullin
• Representative Cases & Transactions
  Cases

  Experience: Representative Transactions: Represented a biopharmaceutical company in licensing patents from AstraZeneca for the development
  commercialization of monoclonal antibody treatments.
  Represented a medical technology company in a strategic license
  collaboration with Thermo Fisher Scientific for the development
  commercialization of genetic testing products using next generation sequencing technology.
  Represented Amgen in a large number of transactions with CROs, universities
  research institutions around the world for clinical trials of several novel drug c
  idates.
  Represented a drug development company in an asset sale, license
  commercialization agreement with Mayne Pharma Group Limited regarding an FDA-approved dermatology product for treating plaque psoriasis.
  Represented Lorem Vascular in the purchase of intellectual property assets related to cell therapies, including medical device technology, from Cytori Therapeutics, with associated intellectual property licenses,
  commercial agreements.
  Represented Atara Biotherapeutics, Inc., in structuring a joint venture with Amgen for developing innovative therapies for patients with chronic diseases.
  Represented Shanghai Fosun Pharmaceutical Co., Ltd., in a series of strategic investments in U.S. diagnostic companies
  related exclusive license, manufacturing
  distribution agreements for the technology in China.
  Represented DJO Global in the acquisition of certain medical device assets from Zimmer Biomet, including post-acquisition transition services, supply
  licensing arrangements.
  Represented Aduro BioTech, Inc., in the acquisition of all GVAX vaccine assets from BioSante Pharmaceuticals, Inc.,
  related technology transfer
  licensing.
  Represented R1 RCM (Nasdaq: RCM) in a strategic outsourcing agreement with Intermountain Healthcare to take over revenue cycle management operations for Utah's largest healthcare system.
  Represented a major healthcare insurance company in negotiating a telemedicine platform services agreement with Teladoc for use by network providers
  members.
  Represented Heritage Provider Network in the intellectual property licensing aspects of a large joint venture with Trinity Health for population health management.
  Represented a large healthcare system in the negotiation of an EMR solution
  integration project with Epic System Corporation.
  Represented Jaguar L
  Rover in a strategic collaboration with Waymo for the development of autonomous vehicles using the Jaguar I-PACE for Waymo's driverless robotaxi service.
  Represented Continental Automotive in a strategic partnership with Aurora to develop the first commercially scalable autonomous driving system for the trucking industry.
  Represented Pony.ai in a collaboration agreement with a major automobile manufacturer for an autonomous vehicle robotaxi project.
  Represented a major automotive technology company in a license
  joint development agreement with a chip manufacturer for the design
  deployment of self-driving vehicle control units.
  Represented adidas AG in the sale of Taylor Made Golf Company, including all IT transition services
  commercial arrangements worldwide.
  Represented Ingram Micro (NYSE: IM) in its intellectual property licenses
  transition services arrangements for the acquisition the Odin Service Automation platform
  associated cloud management technologies from Parallels.

  Transactions

  Representative Transactions::; Technology Transactions, Outsourcing and Joint Ventures; Represented R1 RCM (Nasdaq: RCM) in a strategic outsourcing agreement with Intermountain Healthcare to take over revenue cycle management operations for Utah's largest healthcare system.; Represented Shanghai Fosun Pharmaceutical Co., Ltd. in a series of strategic investments in U.S. diagnostic companies and related exclusive license, manufacturing and distribution agreements for the technology in China.; Represented Heritage Provider Network in the intellectual property licensing aspects of a large joint venture with Trinity Health for population health management.; Represented Atara Biotherapeutics, Inc. in structuring a joint venture with Amgen and Kleiner Perkins Caufield & Byers for developing innovative therapies for patients with chronic diseases.; Represented Elcelylx Therapeutics, Inc. in a spin-off of assets into Nazura BioHealth, Inc.; Represented Amgen (Nasdaq: AMGN) in a large number of transactions with CROs, universities and research institutions around the world for clinical trials of several novel drug candidates.; Represented a publicly-traded pharmaceutical company in a series of development and manufacturing agreements (both clinical and commercial) in Europe and Asia.; Represented Spy Optic in its licensing, endorsement, sponsorship, international distribution and manufacturing transactions.; Represented Zeebo, Inc. in a joint venture with Qualcomm for the development of a video game console, as well as in its international distribution and licensing transactions.; Represented Electronic Arts (EA) (NASDAQ: ERTS) in the license and development of mobile video game applications.